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Abstract
Since the first description of cellular auto-
fluorescence over a century ago, we have now
come to appreciate that autofluorescence
should not be discarded as a biological artifact
but embraced as a biological phenomenon with
potentially important cellular relevance.
Indeed, cellular and tissue autofluorescence
has been attributed to a spectrum of unrelated
molecules such as porphyrins, vitamins (vita-
min A, riboflavin, thiamine), structural pro-
teins, lipofuscin and ceroid pigments. We have
recently shown that freshly isolated epithelial
cancer stem cells (CSCs) bear autofluorescent
vesicles in the cytoplasm. Our studies defini-
tively prove that riboflavin and not lipofuscin is
the source of autofluorescence in CSCs as the
inhibition of ATP and not autophagy elimi-
nates CSC autofluorescence, that the ATP-
dependent transporter ABCG2, for which
riboflavin is a substrate, is overexpressed in
autofluorescent CSCs and co-localizes with the
membrane of intracellular autofluorescent
vesicles, the ABCG2-specific inhibitor
Fumitremorgin C reversibly eliminates CSC
autofluorescence, riboflavin is a substrate for
ABCG2, and only the addition of riboflavin to
vitamin-deprived CSC cultures is capable of
restoring autofluorescence. Thus, the sum of
these data unequivocally supports the conclu-
sion that the source of CSC autofluorescence
is the vitamin riboflavin.
Introduction
We appreciate Prof. Di Guardo’s interest in
our recent work published in Nature Methods
where we describe that a subpopulation of can-
cer stem cells (CSCs) present in numerous
epithelial solid tumors contains intracellular
autofluorescent vesicles. These allow for the
prospective isolation, purification and biologi-
cal characterization of CSCs.1 We would like to
take this opportunity, however, to formally
address specific issues raised by Prof. Di
Guardo regarding the source of the autofluo-
rescent phenotype we describe and character-
ize in our study.2
Since the first description of cellular auto-
fluorescence over a century ago, we have now
come to appreciate that autofluorescence
should not be discarded as a biological artifact
but embraced as a biological phenomenon with
potentially important cellular relevance.
Indeed, cellular and tissue autofluorescence
has been attributed to a spectrum of unrelated
molecules such as porphyrins, vitamins (vita-
min A, riboflavin, thiamine), structural pro-
teins, lipofuscin and ceroid pigments.3 While
we definitively show that riboflavin (vitamin
B2) is the underlying causative agent of auto-
fluorescence in epithelial CSCs, Prof. Di
Guardo takes the liberty to dispute our exhaus-
tive investigation by proposing lipofuscin as an
alternative source and additionally raises the
notion that not considering lipofuscin and lipo-
fuscin-like compounds among the biomolecular
substrates potentially-putatively responsible for
the autofluorescence specifically detected in
epithelial CSCs could be regarded as a concep-
tual error leading to a methodological slip. To
avoid confusing the reader, we here address
Prof. Di Guardo’s concern and explain why his
claim is unprecedented and incorrect. 
Intracellular autofluorescenceand spectral profiles
Autofluorescence in cells and tissues can be
detected due to the presence of intrinsic bio-
molecules acting as endogenous fluorophores,
with favourable spectral properties and quan-
tum efficiency (excitation/emission ranges
within the blue region where most endoge-
nous fluorophores emit).3 Specifically, the
auto-fluorescence in the cytoplasm of epithe-
lial CSCs has a distinct green spectral profile
(excitation and emission 480-490 nm and 530-
540 nm, respectively) and can be excited only
with a standard blue laser, but not with yellow-
green (e.g., 561 nm) or red (e.g., 640 nm)
lasers. Riboflavin has a near identical spectral
profile (excitation and emission 480-490 nm
and 530-540 nm, respectively), while lipofus-
cin and lipofuscin-like lipopigments have a
much broader spectral profile with excitation
and emission wavelengths of 400-500 nm and
480-700 nm, respectively (Figure 1). Thus, the
autofluorescence of lipofuscin or lipofuscin-
like lipopigments covers the yellow-red region,
depending on the variability of its composition
(e.g., proteins, lipids, carotenoids and
metals).4 Lipofuscins have been shown to con-
sist, in part, of undigested material (e.g., lipids
and covalently cross-linked proteins) remain-
ing from phagocytosis and/or autophagy and
therefore they can be occasionally observed in
the cell cytoplasm as intracytoplasmic gran-
ules.5-7 In our work, we specifically excluded a
link between CSC autofluorescence and
autophagy, and CSC autofluorescent vesicles
also did not co-localize with lipid droplets or
lysosomes, as demonstrated by co-staining
with Nile red or LysoTracker, respectively.1 In
addition, autofluorescence was not observed in
paraffin sections of pancreatic tumors (data
not shown), which is in contrast to lipofuscin
autofluorescence, which is not lost when tis-
sues are formalin fixed and paraffin embed-
ded, likely due to its non-degradable makeup.8
While the spectral data and the aforemen-
tioned experimental observations alone would
argue that the source of the CSC autofluores-
cence we observe in freshly digested or cul-
tured tumors is not lipofuscin, our ABCG2-spe-
cific studies leave no doubt that riboflavin and
not lipofuscin is the source of autofluores-
cence in CSCs. Specifically, we show that inhi-
bition of ATP and not autophagy eliminates
CSC autofluorescence, that the ATP-dependent
transporter ABCG2 is overexpressed in auto-
fluorescent CSCs and co-localizes with the
membrane of intracellular autofluorescent
vesicles, the ABCG2-specific inhibitor
Fumitremorgin C9 reversibly eliminates CSC
autofluorescence, riboflavin is a substrate for
ABCG2,10 and only the addition of riboflavin to
vitamin-deprived CSC cultures is capable of
restoring autofluorescence. Thus, the sum of
these data unequivocally supports the conclu-
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sion that the source of CSC autofluorescence
is the vitamin riboflavin. 
Concluding remarks
We thank the journal for sharing Prof. Di
Guardo’s opinion, and we hope that our
response provides evidence-based clarity to
support our claim that riboflavin and not lipo-
fuscin is the source of autofluorescence in
epithelial CSCs and that no methodological
slip has been made. These minor quibbles,
however, should not distract from the clear
consensus of all the authors that autofluores-
cence in CSCs represents an important
advance in our understanding of these biolog-
ically important cells in the context of cancer
and chemoresistance.
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                                                                                           Views and Comments
Figure 1. Autofluorescence in epithelial cancer stem cells. Confocal image of cancer cells derived from primary pancreatic cancer tissue
showing a subset of cells with autofluorescent cytoplasmic vesicles (left). Spectral analysis of the autofluorescence demonstrated an
emission maximum at 532 nm (upper right). Representative emission spectra of riboflavin and lipofuscin (lower right). Fluo, autoflu-
orescence; Nile Red, lipid droplets; Hoechst, nuclear staining. 
EJH_2015_01-45/78.qxp_Hrev_master  11/03/15  13:40  Pagina 75
